JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
Center Bancorp
CNOB
$1.54B
| $24.4M | ﹤0.01% |
1,007,505
+417,262
| +71% | +$10.3M |
2017 Q3
21 quarters
|
|
1477
Prothena Corp
PRTA
$425M
| $24.4M | ﹤0.01% |
404,551
+122,369
| +43% | +$7.17M |
2014 Q4
32 quarters
|
|
1478
Cogent Communications
CCOI
$446M
| $24.4M | ﹤0.01% |
426,778
-34,539
| -7% | -$1.89M |
2015 Q1
31 quarters
|
|
1479
PUT
TSMC
TSM
$2.52T
| $24.4M | ﹤0.01% |
326,900
| – | – |
2021 Q1
7 quarters
|
|
1480
AdaptHealth
AHCO
$774M
| $24.3M | ﹤0.01% |
1,266,836
-18,440
| -1% | -$390K |
2020 Q2
10 quarters
|
|
1481
iShares US Healthcare ETF
IYH
$3.94B
| $24.3M | ﹤0.01% |
429,110
+374,785
| +690% | +$20.7M |
2013 Q2
38 quarters
|
|
|
1482
PUT
McDonald's
MCD
$164B
| $24.3M | ﹤0.01% |
92,300
-37,100
| -29% | -$9.79M |
2013 Q2
38 quarters
|
|
1483
CACI
CACI
$13.9B
| $24.1M | ﹤0.01% |
80,012
-8,558
| -10% | -$2.5M |
2013 Q2
38 quarters
|
|
1484
PUT
GE Aerospace
GE
$319B
| $24M | ﹤0.01% |
460,180
+24,237
| +6% | +$1.19M |
2014 Q2
34 quarters
|
|
1485
iShares Floating Rate Bond ETF
FLOT
$11.1B
| $24M | ﹤0.01% |
477,087
-342,388
| -42% | -$17.2M |
2013 Q2
38 quarters
|
|
1486
CRISPR Therapeutics
CRSP
$5.52B
| $24M | ﹤0.01% |
589,623
-23,267
| -4% | -$1.23M |
2018 Q2
18 quarters
|
|
|
EQC
1487
DELISTED
Equity Commonwealth
EQC
| $24M | ﹤0.01% |
959,542
-146,829
| -13% | -$3.75M |
2013 Q2
38 quarters
|
|
|
AXNX
1488
DELISTED
Axonics, Inc. Common Stock
AXNX
| $24M | ﹤0.01% |
383,153
-21,541
| -5% | -$1.43M |
2018 Q4
16 quarters
|
|
1489
CALL
Starbucks
SBUX
$108B
| $23.9M | ﹤0.01% |
241,300
+132,100
| +121% | +$12.5M |
2016 Q1
27 quarters
|
|
1490
Jones Lang LaSalle
JLL
$14B
| $23.9M | ﹤0.01% |
149,951
-27,329
| -15% | -$4.36M |
2013 Q2
38 quarters
|
|
1491
Williams-Sonoma
WSM
$28.3B
| $23.9M | ﹤0.01% |
415,516
-2,948
| -0.7% | -$177K |
2013 Q2
38 quarters
|
|
1492
CALL
Viatris
VTRS
$20.3B
| $23.8M | ﹤0.01% |
2,141,500
-269,000
| -11% | -$2.81M |
2021 Q2
6 quarters
|
|
1493
Five Below
FIVE
$11.9B
| $23.8M | ﹤0.01% |
134,313
-2,673
| -2% | -$420K |
2015 Q3
29 quarters
|
|
1494
First Merchants
FRME
$2.5B
| $23.8M | ﹤0.01% |
577,827
+15,146
| +3% | +$640K |
2013 Q2
38 quarters
|
|
1495
Allogene Therapeutics
ALLO
$515M
| $23.7M | ﹤0.01% |
3,770,283
-195,337
| -5% | -$1.81M |
2018 Q4
16 quarters
|
|
1496
Coupang
CPNG
$25.5B
| $23.7M | ﹤0.01% |
1,609,264
+759,088
| +89% | +$13.4M |
2021 Q1
7 quarters
|
|
1497
Option Care Health
OPCH
$3.51B
| $23.6M | ﹤0.01% |
785,791
-686,743
| -47% | -$21.3M |
2016 Q3
25 quarters
|
|
1498
iShares US Real Estate ETF
IYR
$4.08B
| $23.6M | ﹤0.01% |
280,244
+222,271
| +383% | +$18.7M |
2013 Q2
38 quarters
|
|
1499
Wyndham Hotels & Resorts
WH
$5.32B
| $23.6M | ﹤0.01% |
330,698
+23,536
| +8% | +$1.66M |
2018 Q2
18 quarters
|
|
1500
Legend Biotech
LEGN
$3.61B
| $23.6M | ﹤0.01% |
472,401
-42,333
| -8% | -$2.05M |
2020 Q2
10 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.